Showing results (11-20 of 119) with videos related to
Sort By:
Pageof 12
Clinical Lymphoma, Myeloma & Leukemia|October 7, 2016
Richter's Transformation in the Era of Kinase Inhibitor Therapy: A ReviewEmily C Ayers, Anthony R MatoClinical Advances in Hematology & Oncology : H&O|April 12, 2021
The evolving use of minimal residual disease (MRD) assessment in chronic lymphocytic leukemiaBruce D Cheson, Anthony R MatoHematology. American Society of Hematology. Education Program|December 4, 2020
Approaches for relapsed CLL after chemotherapy-free frontline regimensLindsey E Roeker, Anthony R MatoBone Marrow Transplantation|April 25, 2006
Autologous stem cell transplant in ALL: who should we be transplanting in first remission?A R Mato, S M LugerThe Oncologist|May 9, 2012
Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideAnthony R Mato, Tatyana Feldman, André GoyCurrent Opinion in Hematology|February 28, 2008
Novel strategies for relapsed and refractory acute myeloid leukemiaAnthony R Mato, Alicia Morgans, Selina M LugerDrugs|December 21, 2021
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of ChemoimmunotherapyLindsey E Roeker, Meghan Thompson, Anthony R MatoBlood|November 16, 2018
Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?Maryam Sarraf Yazdy, Anthony R Mato, Bruce D ChesonMicrobial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998I Santos Sanches, R Mato, H de Lencastre, et al.Microbial Drug Resistance (Larchmont, N.Y.)|October 1, 1996
Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospitalR Mato, H de Lencastre, R B Roberts, et al.Pageof 12